Literature DB >> 25267057

Sight-threatening diabetic eye disease: an update and review of the literature.

Richard J Symes1, Gerald Liew1, Adnan Tufail1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25267057      PMCID： PMC4173734          DOI： 10.3399/bjgp14X682033

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  8 in total

1.  Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.

Authors:  P Andrew Pearson; Timothy L Comstock; Michael Ip; David Callanan; Lawrence S Morse; Paul Ashton; Brian Levy; Eric S Mann; Dean Eliott
Journal:  Ophthalmology       Date:  2011-08       Impact factor: 12.079

2.  Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy.

Authors:  Walter T Ambrosius; Ronald P Danis; David C Goff; Craig M Greven; Hertzel C Gerstein; Robert M Cohen; Matthew C Riddle; Michael E Miller; John B Buse; Denise E Bonds; Kevin A Peterson; Yves D Rosenberg; Letitia H Perdue; Barbara A Esser; Lea A Seaquist; James V Felicetta; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2010-03

Review 3.  Fenofibrate - a potential systemic treatment for diabetic retinopathy?

Authors:  Tien Yin Wong; Rafael Simó; Paul Mitchell
Journal:  Am J Ophthalmol       Date:  2012-07       Impact factor: 5.258

Review 4.  Diabetic retinopathy.

Authors:  Ning Cheung; Paul Mitchell; Tien Yin Wong
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

5.  Effects of medical therapies on retinopathy progression in type 2 diabetes.

Authors:  Emily Y Chew; Walter T Ambrosius; Matthew D Davis; Ronald P Danis; Sapna Gangaputra; Craig M Greven; Larry Hubbard; Barbara A Esser; James F Lovato; Letitia H Perdue; David C Goff; William C Cushman; Henry N Ginsberg; Marshall B Elam; Saul Genuth; Hertzel C Gerstein; Ulrich Schubart; Lawrence J Fine
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

6.  Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008.

Authors:  C Bunce; W Xing; R Wormald
Journal:  Eye (Lond)       Date:  2010-09-17       Impact factor: 3.775

7.  Glitazone use associated with diabetic macular edema.

Authors:  Donald S Fong; Richard Contreras
Journal:  Am J Ophthalmol       Date:  2009-02-01       Impact factor: 5.258

8.  Critical appraisal of ranibizumab in the treatment of diabetic macular edema.

Authors:  Michael W Stewart
Journal:  Clin Ophthalmol       Date:  2013-06-24
  8 in total
  2 in total

1.  Vision loss as a presenting symptom of type 2 diabetes mellitus.

Authors:  Jacintha Gong; Thomas G M Cormack
Journal:  Br J Gen Pract       Date:  2014-12       Impact factor: 5.386

2.  Optical Quality and Intraocular Scattering in the Diabetic Eye without Diabetic Retinopathy.

Authors:  Jianting Liu; Xiaogang Wang; Jinfeng Wang; Haike Guo
Journal:  Optom Vis Sci       Date:  2019-04       Impact factor: 1.973
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.